Drug intelligence / Profile preview

Xiao'er Jianpi Granules

Development stage
Unknown
Lead developer
Jiangsu Kanion Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Xiao'er Jianpi Granules is a Traditional Chinese Medicine (TCM) product developed by Jiangsu Kanion Pharmaceutical Co., Ltd., specifically formulated for pediatric use. It is primarily indicated for the treatment of functional dyspepsia and related digestive disorders in children, such as anorexia, abdominal distension, and diarrhea resulting from "spleen deficiency and food stagnation." The formulation is a complex herbal mixture typically containing ingredients such as Astragalus, Codonopsis, Atractylodes, and Hawthorn, which work synergistically to tonify the spleen, harmonize the stomach, and promote digestion. Pharmacologically, the granules are thought to improve gastrointestinal motility and modulate the secretion of digestive enzymes and gastrointestinal hormones like motilin and gastrin, thereby alleviating symptoms of indigestion and improving nutrient absorption in pediatric patients.

Brand names
Xiao'er Jianpi Granules
Other names
Xiaoer Jianpi KeliPediatric Spleen-Strengthening Granules
02

Targets

MLNR (Human motilin receptor)

Beyond the preview

Go deeper on Xiao'er Jianpi Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xiao'er Jianpi Granules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call